You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Cellular therapies
96 Decitabine gene modulation sensitizes human non–small cell lung cancer (NSCLC) to NY-ESO-1 TCR immunotherapy (letetresgene autoleucel; GSK3377794) in vivo

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020261025
Dec 20204804
Jan 202130010
Feb 20213606
Mar 202141011
Apr 20213806
May 20211404
Jun 2021008
Jul 2021002
Aug 20210018
Sep 2021007
Oct 202136021
Nov 202162018
Dec 20212203
Jan 20221000
Feb 20222005
Mar 20223601
Apr 20225907
May 20222401
Jun 20221401
Jul 20222001
Aug 20222004
Sep 20222201
Oct 20221800
Nov 20222204
Dec 20221800
Jan 20231801
Feb 20232201
Mar 20232204
Apr 2023801
May 2023801
Jun 20231600
Jul 20231207
Aug 20231201
Sep 2023800
Oct 20231801
Nov 20231801
Dec 20235001
Jan 20241200
Feb 20241800
Mar 20241600
Apr 20241803
May 20242601
Jun 20241800
Jul 20242802
Aug 20242803
Sep 20244805
Oct 20242807
Nov 20241403
Dec 20243408
Jan 20251606
Feb 2025603
Mar 2025004
Apr 2025003
May 20250011
Jun 2025002
Total13930248